The STOIC Trial: Inhaled Budesonide in the Treatment of Early COVID-19
Background: COVID-19 typically starts as a mild illness that progresses over several days. Most treatment interventions for COVID-19 are focused on hospitalized patients who have progressed past this mild illness. Monoclonal antibodies have been heavily touted in this role for …
